Key result
Colforsin daropate exerted potent coronary vasodilator actions and stimulated adenylate cyclase activity significantly more than isoproterenol, dopamine, and dobutamine in canine heart preparations.
Why the study?
Does colforsin daropate improve cardiovascular variables and adenylate cyclase activity compared to catecholamines in canine isolated heart preparations?
Population
Canine isolated, blood-perfused heart preparations
Comparison
Colforsin daropate vs Isoproterenol, dopamine, and dobutamine
Design
Preclinical
Authors
Loading...
Supports further study of colforsin daropate in heart failure; leaves open clinical translation from canine data.
Does colforsin daropate improve cardiovascular variables and adenylate cyclase activity compared to catecholamines in canine isolated heart preparations?
Colforsin daropate demonstrates potent coronary vasodilator action and adenylate cyclase stimulation compared to catecholamines, suggesting potential utility in severe heart failure.
Yoneyama et al. (2002) studied None (Healthy canine heart preparations) (n=6). Colforsin daropate vs. Isoproterenol, dopamine, and dobutamine was evaluated on Adenylate cyclase activity and cardiovascular parameters (sinoatrial rate, developed tension, coronary blood flow). Colforsin daropate exerted potent coronary vasodilator actions and stimulated adenylate cyclase activity significantly more than isoproterenol, dopamine, and dobutamine in canine heart preparations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: